Track Sage Therapeutics's total liabilities ($54M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2025), SAGE shows a total liabilities of $54M. That compares with $69M in the prior-year period — down 21.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SAGE's total liabilities is now $54M (was $69M) — a 21.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sage Therapeutics is outperforming or lagging.
Tracking SAGE's total liabilities over time shows whether Sage Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $54M That compares with $69M in the prior-year period — down 21.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Sage Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $54M) with ownership activity and broader fundamentals.
Sage Therapeutics's total liabilities is $54M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.